An open-label, two-period, crossover, pharmacokinetic study of abacavir and its intracellular anabolite carbovir triphosphate following once-daily and twice-daily administration of abacavir in HIV-infected subjects
Phase of Trial: Phase I
Latest Information Update: 06 Jul 2013
At a glance
- Drugs Abacavir; Lamivudine/abacavir; Lamivudine/zidovudine/abacavir
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 09 Oct 2008 Checked against ClinicalTrials.gov record - last updated 9 Oct 2008.
- 10 Aug 2007 Status changed from in progress to completed.
- 12 May 2007 New trial record.